Therefore, exploration, in to what extent, the involvement of XPO1 overexpression in CRC characteristics in tissue samples, considering the histopathological characteristics and proliferation activity, in association with the NF-κB may be helpful in line of individualizing of patients treatment using XPO1 inhibitor. Here, NFKB1 is linked to colorectal carcinoma.